Osteotide 750mg Injection
Marketer
Virchow Biotech Pvt Ltd
Salt Composition
Teriparatide (750mg)
Overview Osteotide 750mg Injection
Teriparatide 750mcg injection, a synthetic parathyroid hormone analog, treats severe osteoporosis in men and postmenopausal women at high fracture risk. Its mechanism involves stimulating bone formation, thereby increasing bone mineral density and reducing vertebral fracture incidence. Administered subcutaneously by a healthcare provider or self-injected, this medication requires consistent daily dosing for optimal efficacy. Treatment typically lasts up to two years, but adherence to the prescribed course is vital, even with symptom improvement. Refrigerate between 2°C and 8°C. Common adverse effects include arthralgia, local injection site reactions (pain, edema, erythema), and lower limb cramps. Report persistent or bothersome side effects to your physician. Prior to commencing therapy, disclose any renal history, including nephrolithiasis, due to potential hypercalcemia or hypercalciuria. Pregnant or lactating individuals should seek medical counsel before initiating treatment. Your doctor might order bone densitometry to track treatment progress.
Uses of Osteotide 750mg Injection
Brittle bone disease
Major Benefits of Osteotide 750mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Osteotide 750mg Injection:
- Joint pain
- Injection site reactions (pain, swelling, redness)
- Nausea
- Leg cramps
How to use Osteotide 750mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Osteotide 750mg Injection works:
A synthetic analog of the naturally occurring parathyroid hormone (PTH), Osteotide 750mg Injection stimulates osteoblast proliferation and activity. This results in enhanced bone strength and a reduced fracture risk.
SAFETY ADVICE
AlcoholCAUTION
Using alcohol while receiving Osteotide 750mg Injection requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Osteotide 750mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Osteotide 750mg Injection use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Administration of Osteotide 750mg Injection can induce drowsiness, visual disturbances, and dizziness. Driving should be avoided if these effects manifest.
KidneyCAUTION
Patients with kidney impairment should receive Osteotide 750mg Injection cautiously, potentially requiring dose modification. Severe kidney disease contraindicates the use of Osteotide 750mg Injection; physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Osteotide 750mg Injection to individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take Osteotide 750mg Injection :
Should you forget a scheduled Osteotide 750mg Injection, administer it at your earliest convenience. Nevertheless, if your next dose is imminent, omit the missed injection and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Osteotide 750mg Injection
| Label | Value |
|---|---|
| Chemical Type | Parathyroid Hormone-Related Peptides |
| Developing Habits | No. |
| Treatment Category | Endocrine Signals |
3,018 People bought this recently